Shafiq A Khan

Title: Shafiq A Khan: Innovator in Cancer Research

Introduction

Shafiq A Khan is a notable inventor based in Mableton, GA (US). He has made significant contributions to the field of cancer research through his innovative work on small molecule inhibitors. His research focuses on the G(alpha)i2 protein and its implications in cancer cell migration.

Latest Patents

Shafiq A Khan holds 1 patent for his invention titled "Small molecule inhibitors of G(alpha)i2 protein and uses thereof." This patent discloses novel compounds and methods that maintain the Gα2 protein in its inactive GDP-bound state. The compounds described in the patent have shown promise in inhibiting the migratory behavior of various cancer cell lines, including breast and ovarian cancer. Specifically, the compounds block the activation of Gα2 in oxytocin-stimulated prostate cancer PC3 cells and inhibit the migratory capability of DU145 cells that overexpress a constitutively active form of Gα2.

Career Highlights

Throughout his career, Shafiq A Khan has worked with esteemed institutions such as Clark Atlanta University and Georgia Tech Research Corporation. His research has contributed to a deeper understanding of cancer biology and potential therapeutic approaches.

Collaborations

Shafiq has collaborated with notable colleagues, including Silvia Caggia and Adegboyega K Oyelere. These collaborations have further enriched his research and innovation in the field.

Conclusion

Shafiq A Khan's work exemplifies the impact of innovative research on cancer treatment. His contributions through patents and collaborations continue to advance the understanding of cancer biology and potential therapeutic strategies.